BP
GILD icon

BNP Paribas’s Gilead Sciences GILD Stock Holding History

BNP Paribas’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
118,671
+20,329
+21% +$2.68M 0.41% 48
2026
Q1 		$13.7M Buy
98,342
+5,789
+6% +$811K 0.44% 48
2025
Q4 		$11.4M Buy
92,553
+23,078
+33% +$2.8M 0.33% 57
2025
Q3 		$7.71M Sell
69,475
-16,020
-19% -$1.82M 0.23% 72
2025
Q2 		$9.47M Buy
85,495
+150
+0.2% +$16K 0.31% 64
2025
Q1 		$9.56M Buy
85,345
+10,946
+15% +$1.13M 0.4% 64
2024
Q4 		$6.87M Sell
74,399
-2,996
-4% -$270K 0.04% 75
2024
Q3 		$6.49M Sell
77,395
-4,020
-5% -$307K 0.27% 63
2024
Q2 		$5.58M Buy
81,415
+2,810
+4% +$188K 0.28% 64
2024
Q1 		$5.76M Buy
+78,605
New +$6.04M 0.27% 71

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas's GILD Position: Q2 2026 in Review

BNP Paribas increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $2.68M and bringing the position to 118,671 shares worth $15M. The position accounts for 0.41% of the portfolio, ranked #48.

BNP Paribas first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BNP Paribas held 118,671 shares of Gilead Sciences worth $15M as of Q2 2026.
  • BNP Paribas bought 20,329 Gilead Sciences shares in Q2 2026, an estimated $2.68M.
  • Gilead Sciences made up 0.41% of BNP Paribas's portfolio in Q2 2026, its #48 holding.
  • BNP Paribas first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.